Facebook
Twitter
Telegram
Report an ErrorNeos Therapeutics, Inc. Financial Statements 2011-2024 | NEOS
Annual Financial Statements Neos Therapeutics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
- | 80.6 M | 67.8 M | 275 M | 95.5 M | 103 M | - | - | - | - |
Shares |
- | 49.7 M | 32.3 M | 24.8 M | 16.1 M | 7.58 M | - | - | - | - |
Net Income |
- | -16.9 M | -51.7 M | -66.2 M | -83.3 M | -30.8 M | -20.8 M | -19 M | - | - |
Revenue |
- | 64.6 M | 50 M | 25 M | 9.15 M | 3.79 M | 758 K | 1.04 M | - | - |
EBITDA |
- | -6.22 M | -40 M | -54 M | -73.1 M | -23.3 M | -15.8 M | -14.9 M | - | - |
Operating Expenses |
- | 49.9 M | 66.6 M | 69.6 M | 74.1 M | 24.8 M | 15.9 M | 15.6 M | - | - |
General and Administrative Expenses |
- | 13.2 M | 13.9 M | 13.8 M | 12.6 M | 7.47 M | - | 5.47 M | - | - |
All numbers in USD currency